Skip to main content
Focused investors/David Rolfe

David Rolfe - Wedgewood Partners

As of Q2 2026, David Rolfe reported 18 long-equity positions worth $484.43M in aggregate.

Copy-investor backtest

Latest quarter
+6.97%
1-year
+5.05%
3-year
+52.19%
5-year
+53.54%
3-year vs S&P 500
-21.05%
5-year vs S&P 500
-20.55%
5-year top 5
+92.83%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when David Rolfe files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 12 of 17 rows. Rows without a quote are marked unavailable.

1ESRXEXPRESS SCRIPTS COM9.02%-1,287,354$57.53MNo quoteNo quote
2VVISA COM9.02%-566,481$57.52M$101.53No quote
3GOOGLGOOGLE COM8.85%-87,363$56.43M$645.90No quote
4GILDGILEAD SCIENCES COM7.79%-1,213,955$49.69M$40.93No quote
5QCOMQUALCOMM COM7.26%-845,864$46.27M$54.70No quote
6PEPPERRIGO COM6.61%-433,369$42.17M$97.30No quote
7VRSKVERISK ANALYTICS COM6.09%-967,239$38.82M$40.13No quote
8ISRGINTUITIVE SURGICAL COM5.60%-77,128$35.71M$463.01No quote
9TEVATEVA PHARMACEUTICAL COM5.44%-858,982$34.67M$40.36No quote
10CMICUMMINS COM5.43%-393,219$34.61M$88.02No quote
11CTSHCOGNIZANT TECHNOLOGY SOLUTIONS COM5.21%-516,199$33.2M$64.31No quote
12VARVARIAN MEDICAL SYSTEMS COM5.17%-490,990$32.96MNo quoteNo quote
13JECSCHLUMBERGER COM4.53%-422,516$28.86MNo quoteNo quote
14EMCEMC COM4.50%-1,330,782$28.67MNo quoteNo quote
15SRCLSTERICYCLE COM3.45%-282,673$22.03MNo quoteNo quote
16NOVNATIONAL OILWELL VARCO COM3.34%-313,325$21.3M$67.99No quote
17EXPDEXPEDITORS INTERNATIONAL COM2.70%-420,029$17.2M$40.96No quote